Amodiaquine is an antimalarial medicine that has been used in the treatment of malaria. While medicines can be important in treating disease, researchers also study how some drugs may affect other organs and biological functions.

One area that has attracted attention is female reproductive health.

A study conducted using adult female Sprague-Dawley rats investigated whether amodiaquine hydrochloride (AQ.HCl) could affect ovarian function and whether vitamin E could reduce some of these effects.

What Did the Researchers Investigate?

The researchers studied 30 adult female rats and examined the effects of amodiaquine combined with vitamin E on several aspects of reproductive function.

They looked at:

• The length and pattern of the oestrous cycle
• Ovulation
• Reproductive hormones including FSH, LH and prolactin
• Antioxidant enzymes such as superoxide dismutase (SOD) and catalase (CAT)

The researchers were particularly interested in oxidative stress because antioxidants such as vitamin E can help protect cells against damage caused by reactive molecules.

What Happened to the Reproductive Cycle?

The study found that rats receiving amodiaquine together with vitamin E experienced a longer oestrous cycle, particularly because they spent more time in the diestrus phase.

This suggests that vitamin E did not completely prevent the changes in reproductive cycling associated with amodiaquine exposure.

However, there was an encouraging finding when the researchers examined ovulation.

Vitamin E and Ovulation

The number of oocytes, or eggs, released by rats receiving amodiaquine and vitamin E was comparable to the control animals, particularly at the lower dose.

The researchers interpreted this as evidence that vitamin E may have helped counter some of the adverse effects of amodiaquine on ovarian function and follicle development.

The study also found no significant differences in the measured serum concentrations of FSH, LH and prolactin between the treated animals and controls.

Why Might Vitamin E Help?

Vitamin E is a fat-soluble antioxidant. Antioxidants help the body manage oxidative stress, which occurs when potentially damaging reactive molecules overwhelm the body’s protective systems.

The researchers suggested that vitamin E’s antioxidant properties may have contributed to its protective effect on ovarian function.

However, this does not mean that vitamin E can prevent all drug-related reproductive effects or that women taking amodiaquine should automatically take vitamin E supplements.

What Does This Mean for Women?

The findings are interesting, but they need to be interpreted carefully.

This was an animal study, not a clinical trial in women. Therefore, the results cannot be directly used to conclude that amodiaquine causes infertility in women or that vitamin E can prevent such effects.

Instead, the research provides useful evidence for further investigation into how certain medications, oxidative stress and ovarian function may interact.

The Takeaway

The study highlights an important connection between medication exposure, oxidative stress and reproductive health.

In rats, amodiaquine exposure was associated with changes in ovarian function, while vitamin E appeared to provide some protective effects, particularly regarding ovulation. However, vitamin E did not completely prevent changes in the reproductive cycle.

For humans, the most important message is simple: medications should be used appropriately and under professional guidance.

If you are taking an antimalarial medicine and have concerns about fertility, menstrual changes or other side effects, speak with a qualified healthcare professional rather than adding supplements or stopping medication on your own.

This article is based on animal research and is intended for educational purposes. Findings in rats do not necessarily predict effects in humans and should not be used as a substitute for medical advice.